Something that nobody is talking about is the fact that this company actually , now has earnings . They are coming from their recent acquisitions . Say what you want , but that's a first . They are more diversified than ever into the testing of disease and bioterrorism .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.